Pneumonia kills nearly 1 million children under five and pneumococcal disease is the leading cause of pneumonia. Countries introducing pneumococcal vaccines with Gavi support could prevent 500,000 early deaths by 2020. Download high resolution PDF version
At Kathmandu’s Patan hospital, Gavi is funding impact studies on two vaccines that protect children against the main causes of deadly pneumonia: Haemophilus influenzae type b (Hib) and pneumococcal disease. Three doctors who are leading these studies identify four ways in which Patan’s pioneering research is shaping Nepal’s immunisation policy.
The Gavi Campaign is a 501(c)(3) US public charity whose charitable mission includes supporting immunization programs in developing countries. Contributions to the Gavi Campaign are managed by its Board and disbursed at the Board’s discretion, to further the mission, including programs in support of Gavi, the Vaccine Alliance.